glp 1 gip and glucagon GLP-1 receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal triple action glp 1 acting

Iles, L

Diabetes & Metabolism 34 : S65-S72

According to Novo Nordisk and independent reporting, the approval was based on strong clinical trial results demonstrating meaningful weight loss outcomes

Ini karena kandungan tersebut bisa menghambat produksi melanin dan mencerahkan kulit

It has been shown that perilesional melanocytes have a lower ratio of Bcl-2/Bax than control melanocytes, suggesting that melanocytes from patients with vitiligo are more susceptible to apoptosis activation due to altered Bcl-2 and Bax expression and that the balance between pro-apoptotic and anti-apoptotic proteins in vitiligo melanocytes is shifted towards apoptosis [44]